Enhertu is a drug that can help extend the life of certain people with incurable HER2-low secondary breast cancer. But it's been rejected for use on the NHS in England.
This means thousands of people will be denied access to a drug that could give them the hope of more time to live.
We’ve been working hard to get all parties to find a solution to make Enhertu available to the people who so desperately need it, across the UK.
Despite securing the Health Secretary’s intervention, which led to further talks between the NHS England and the drug companies, we’re devastated that NICE, NHS England, Daiichi Sankyo and AstraZeneca have failed to find a way forward.
We’re now turning our attention to trying to fix the problems with the drug approvals system that led to Enhertu being rejected for use on the NHS. We’re asking MPs to join us in parliament to find out what’s wrong with the system and how they can help us to fix it. Please ask your own MP to come along to find out more
And this is just the start, there’ll be more chances for you to get involved to help us make sure people with incurable secondary breast cancer can get the drugs they need.
Ask your MP to join us in parliament
Please invite your MP to our event - it's a chance for them to find out what's wrong with the drugs approvals system and how they can help us fix it
Find out more about our campaigns
-
Campaign with us
We're campaigning get people affected by breast cancer the best treatment, services and care.
-
Campaign successes
Thanks to you, our campaigns are making things better for people living with or affected by breast cancer. Learn about our recent successes.
-
Sign our #NoTimeToWaste petition
Join us in calling on the government and NHS England to run a national breast screening awareness campaign.
